Morgan Stanley Triples 2026 China Robot Forecast to 50,000 Units
What You Need to Know
- Morgan Stanley raised 2026 Chinese humanoid robot forecast to 50,000 units from initial 14,000 estimate.
- China’s humanoid market projected to reach $15 billion by 2030 with 446,000 annual shipments.
- China accounted for over 80% of global humanoid robot deployments in 2025, led by domestic manufacturers.
- Chinese manufacturers have supply chain integration advantages that American competitors cannot quickly replicate.
Morgan Stanley has now raised its 2026 Chinese humanoid robot shipment forecast three times in a single year, landing at 50,000 units after starting January at 14,000. The bank’s equity analyst Sheng Zhong pointed to commercial verification, policy support, and supply-chain feedback as the drivers, and the firm expects China’s humanoid market to reach $15 billion by 2030 with annual shipments of 446,000 units.
The revision pattern matters more than the number itself. Three upward revisions in roughly six months suggests the original forecasting models were calibrated for a slower technology adoption curve, one that Chinese manufacturers appear to have already exited. In 2025, China accounted for more than 80% of the roughly 16,000 humanoid robots deployed globally, with AGIBOT, Unitree, UBTECH, and Leju leading shipments. Unitree alone posted 1.7 billion yuan in 2025 revenue with a 278 million yuan profit, numbers that put it well past the prototype stage. Global humanoid shipments are projected to exceed 50,000 units in 2026, a figure that now looks conservative given the pace of Chinese commercial rollout. The tariff and rare-earth supply chain pressures that complicate U.S. robotics ambitions have not visibly slowed Chinese manufacturers, which have supply chain integration that American competitors cannot replicate quickly.
The gap between Chinese and American humanoid output is not a research gap. It is a production gap.
American firms are still largely moving in hundreds of units where Chinese competitors move in thousands. Figure AI and Tesla each shipped a few hundred or fewer in 2025, against more than 5,000 each for Agibot and Unitree. The U.S. software advantage in robotics AI is real, but software advantage does not close a 10x manufacturing gap in a single product cycle. Agility Robotics is going public via a SPAC deal with Churchill Capital at a $2.5 billion pre-money valuation, and both Unitree and Agibot are preparing IPOs at a combined $13 billion valuation, which suggests capital markets on both sides are pricing in a long runway rather than near-term convergence.
Morgan Stanley’s figures also carry an important caveat: they cover external sales only, excluding units built for internal testing or trials. The real deployment number is likely higher, which means the commercial verification phase China is now in may be further along than even the revised forecast implies.
0 Comments